Photo of Guru P. Sonpavde adventhealthcancerinstitute.com
Nov 14, 2024, 16:22
Guru P. Sonpavde: Largest analysis of association of irAEs efficacy
Guru P. Sonpavde, GU Oncology Director at Advent Health Cancer Institute, shared on X:
“Immunotherapy with atezolizumab for advanced solid tumors cancer- Largest analysis of association of immune related adverse events (irAEs) and efficacy (9521 patients across 14 studies) – Low grade irAEs associated with improved survival, while specific high grade irAEs (colitis, pneumonitis) associated with poor survival- early recognition and treatment of irAEs important.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 16:22
Nov 14, 2024, 16:22
Nov 14, 2024, 16:13
Nov 14, 2024, 16:03
Nov 14, 2024, 15:58
Nov 14, 2024, 15:54
Nov 14, 2024, 15:53
Nov 14, 2024, 15:50
Nov 14, 2024, 15:49
Nov 14, 2024, 15:40